在NSAIDs中的损伤:基于FAERS数据库的真实世界分析
Haojie Xu1, Jiaming Cao1, Hongyi Zhang2
1Guangzhou Hospital of Integrated Traditional and Western Medicine Affiliated to Guangzhou University of Chinese Medicine, Guangzhou, 510800, China.
International urology and nephrology
|November 3, 2024
概括
非类固醇抗炎药 (NSAIDs) 携带损伤的风险,特别是在老年患者中. 布洛芬显示损伤的风险报告最高,而塞莱科克西布的风险最低,大多数事件发生在治疗的早期.
科学领域:
- 药物监督 药物监督 药物监督
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药品安全 药品安全
背景情况:
- 非类固醇抗炎药物 (NSAIDs) 广泛用于治疗疼痛和炎症.
- 无 NSAID 与各种不良事件有关,包括损伤.
- 了解不同NSAIDs的比较风险概况对于患者安全至关重要.
研究的目的:
- 评估与NSAID使用相关的损伤报告风险.
- 为了比较报告中的五种不同NSAID的风险水平和发病时间.
- 为了确定患有NSAID诱导损伤风险较高的患者群体.
主要方法:
- 一项利用FAERS数据库 (2004-2023) 的药监测研究.
- 使用报告几率比率 (ROR) 和贝叶斯信心传播神经网络 (BCPNN) 检测损伤的信号.
- 五种NSAID的发病率,死亡率和发病时间的比较:伊布罗芬,切莱科克西布,阿司匹林,纳普罗森和迪克洛芬雅克.
主要成果:
- 老年患者面临NSAID相关损伤的风险增加.
- 布洛芬的报道频率 (46.7%) 和损伤信号 (ROR 3.3) 是最高的.
- 塞莱科克西布报告频率 (7.3%) 和信号 (ROR 1.4) 最低;阿司匹林死亡率最高 (18.7%).
- 损伤的中位发病时间为6天,79.3%发生在使用30天内.
结论:
- 布洛芬对损伤的信号最高,而赛莱科克西布的信号最低.
- 老年人更容易受到NSAID诱导的损伤.
- 与NSAID相关的损伤通常在治疗的早期表现出来,需要仔细监测患者.
- 这些发现强调了在临床实践中对NSAID相关的脏风险需要保持警.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
Renal Failure: Dose Adjustments
67
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
67
Antihypertensive Drugs: Direct Renin Inhibitors
498
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
498


